OPEN Foundation

Delivering Effective Psychedelic Clinical Trials

 

🗣 Iain Jordan (Clinical Director at Clerkenwell Health, Honorary Senior Lecturer at the University of Oxford) & Clare Knight (Senior Clinical Research Manager at Clerkenwell Health, previously TYPPEX Programme Manager at the University of Cambridge and Research Delivery Manager at NIHR) & Opening by Joost Breeksema (Executive director OPEN Foundation)

⏰ Wednesday 22 May, 8PM CET (7PM GMT, 2PM EST, 11AM PST)

📍 Online (OPEN Community Platform)

Psychedelic clinical trials present unique challenges in design and execution, requiring specialized practices beyond traditional trials. Join Clerkenwell Health, a market expert in designing and delivering psychedelic clinical trials, for an insightful discussion on this topic. Explore trial design, participant recruitment, the various therapy sessions involved, and finally receive valuable tips on becoming a therapist within these cutting-edge trials.

This event is a pre-launch of OPEN Foundation’s Professional Community Membership. We will answer questions regarding the Professional Community Membership at the end of the event.
To be able to sign-up for this event and receive the invitation link, we invite you to fill in the survey by clicking on the button below. 
 
The official launch of the Professional Community Membership will take place in June, at ICPR 2024. 

READY TO ATTEND?

ATTEND FOR FREE AS A MEMBER

Unlock access to this and all exclusive events with leading psychedelic experts and engage in real time through the OPEN Community Membership. Plus, enjoy a community space, a content library, discounts, and more.

ATTEND By filling in the survey


You can attend this event by filling the survey below to help OPEN Foundation understand its audience and community.

ABOUT THE SPEAKERs

Iain Jordan
Iain is a psychiatrist and therapist who has worked in public health services in the UK and Ireland for over years, including 10 years as a Consultant Psychiatrist at Oxford University Hospital NHSFT. He is Clinical Director of Clerkenwell Health, a specialist psychedelic research and practitioner training organisation.  
Clare Knight
Clare has 16 years of experience in the design, set-up and delivery of mental healthcare research, with a focus on psychedelic compounds. She has previously held leadership roles in large research programmes at the National Institute for Health Research (NIHR) and University of Cambridge.

WHAT'S UNIQUE ABOUT THIS EVENT?

Attending this online event is an interactive experience, unlike watching a lecture on YouTube or a webinar. You'll have the chance to connect with the speakers directly and ask questions, allowing you to explore the topic in greater depth.

READY TO ATTEND?

ATTEND FOR FREE AS A MEMBER

Unlock access to this and all exclusive events with leading psychedelic experts and engage in real time through the OPEN Community Membership. Plus, enjoy a community space, a content library, discounts, and more.

ATTEND by filling in the survey


You can attend this event by filling the survey below to help OPEN Foundation understand its audience and community.

ALREADY A MEMBER?

To access the OPEN Community Platform, click the button below. The platform not only live streams all events, but also provides direct access to event recordings.

22 May - Delivering Effective Psychedelic Clinical Trials

X